Results 31 to 40 of about 1,203 (203)

Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau [PDF]

Biologics: Targets & Therapy, 2019
LM Smirnova, E Yu Vertieva, O Yu Olisova, EM AnpilogovaDepartment of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University, Moscow 119991, Russian FederationBackground: Chronic acrodermatitis continua of Hallopeau (ACH) is a ...
Smirnova LM, Vertieva EY, Olisova OY, Anpilogova EM   +3 more
doaj   +2 more sources

Acrodermatitis continua of hallopeau: aggravating factors and treatment outcomes of 96 patients

Journal of Dermatological Treatment
Background Acrodermatitis continua of Hallopeau (ACH) is a rare pustular psoriasis variant predominantly affects the distal phalanges of the fingers and toes.
Liyan Yuan, Xiaoling Yu, Yanqiang Shi, Bin Yang, Xiaohua Wang   +4 more
doaj   +2 more sources

Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report [PDF]

Case Reports in Dermatology, 2017
Acrodermatitis continua of Hallopeau (ACH) is an uncommon inflammatory disease manifesting as sterile pustular eruption of the fingers and toes. The disease is of a chronic relapsing nature and is often refractory to treatment. With longstanding disease,
May Alorainy, Mohammed Alshaya, Ammar Al-Rikabi, Mohammed Ayesh, Fahad Alsaif   +4 more
doaj   +2 more sources

Treatment of acrodermatitis continua of hallopeau with ixekizumab

Journal of Dermatological Treatment, 2019
Acrodermatitis continua of hallopeau (ACH) is a rare chronic inflammatory variant of pustular psoriasis often restricted to the distal portions the digits in the hands and feet. ACH is of a chronic relapsing nature and is invariably recalcitrant to many available topical and systemic anti-psoriatic therapies.
Austinn C. Miller, Timothy E. Holland, David J. Cohen   +2 more
openaire   +3 more sources

Acrodermatitis Continua of Hallopeau: A Diagnostic Challenge. [PDF]

Indian Dermatol Online J, 2023
Mitra D, Bhatnagar A, Kumar M.
europepmc   +3 more sources

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature. [PDF]

Dermatol Ther, 2019
Acrodermatitis continua of Hallopeau (ACH) is a rare pustular psoriasis variant refractory to many conventional treatments. We report the successful treatment with secukinumab of a patient with a long history of ACH with marked onychodystrophy with frank
Galluzzo M, D'Adamio S, Teoli M, Bianchi L, Talamonti M.   +4 more
europepmc   +2 more sources

Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report

Journal of Dermatological Treatment, 2023
Acrodermatitis continua of hallopeau (ACh) is a rare variant of localized pustular psoriasis characterized by chronic recurrent eruptions of sterile pustules of the distal fingers and sometimes toes, as well as the nail apparatus (1).
Diego Orsini, Paolo Iacovelli, Pasquale Frascione, Alessia Pacifico   +3 more
doaj   +2 more sources

Long-term control of refractory acrodermatitis continua of Hallopeau with subcutaneous spesolimab: A case report [PDF]

JAAD Case Reports
Jan Nicolai Wagner, MD, Franziska Zirkenbach, MD, Brigtte Stephan, MD, Carolin Grote, MD, Matthias Augustin, Prof. Dr med   +4 more
doaj   +2 more sources

Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy [PDF]

JAAD Case Reports, 2021
Sara Al-Khawaga, MD, Roopesh Krishnankutty, PhD, Gulab Sher, PhD, Khairunnisa Hussain, MD, Joerg Buddenkotte, MD, PhD, Martin Steinhoff, MD, PhD   +5 more
doaj   +2 more sources

Successful treatment of acrodermatitis continua of hallopeau with an anti-IL-17A agent

Indian Journal of Dermatology, 2021
Sae Inoue, Rei Watanabe, Yosuke Ishitsuka, Yoshiyuki Nakamura, Yasuhiro Fujisawa, Naoko Okiyama, Manabu Fujimoto   +6 more
doaj   +2 more sources